Bone morphogenetic protein 7 promotes resistance to immunotherapy
The mechanisms underlying resistance to immunotherapy are still poorly understood. Here, the authors show that BMP7, a molecule part of the TGF-beta superfamily, suppresses proinflammatory antitumor responses and may represent a target for overcoming resistance to PD1 inhibitors.
Main Authors: | Maria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, Jie Zhang, Ahmed I. Younes, Yue Lu, Marcos R Estecio, Hampartsoum B. Barsoumian, Hari Menon, Mauricio da Silva Caetano, Rishab Ramapriyan, Jonathan E. Schoenhals, Xiaohong Wang, Ferdinandos Skoulidis, Mark D. Wasley, George Calin, Patrick Hwu, James W. Welsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18617-z |
Similar Items
-
Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy
by: Maria Angelica Cortez, et al.
Published: (2020-10-01) -
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
by: Ahmed I. Younes, et al.
Published: (2021-02-01) -
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
by: Hari Menon, et al.
Published: (2020-07-01) -
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
by: Hari Menon, et al.
Published: (2020-06-01) -
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
by: Hari Menon, et al.
Published: (2019-09-01)